Old asthma drug reverses obesity, diabetes and fatty liver in mice – Examiner.com

Old asthma drug reverses obesity, diabetes and fatty liver in mice
Examiner.com
Alan Saltiel, the Mary Sue Coleman director of the Life Sciences Institute at the University of Michigan, reported the discovery that an off-patent drug currently prescribed for the treatment of asthma also reverses obesity, diabetes and fatty liver in
Old drug may point the way to new treatments for diabetes and obesityEurekAlert (press release)

all 2 news articles »

View full post on asthma – Google News

Nanoparticles Stop Multiple Sclerosis In Mice and could treat food allergies … – Next Big Future

Nanoparticles Stop Multiple Sclerosis In Mice and could treat food allergies
Next Big Future
Nanoparticles Stop Multiple Sclerosis In Mice and could treat food allergies, asthma and other autoimmune diseases · Email ThisBlogThis!Share to TwitterShare to Facebook · Tweet · NBC News – Researchers trying to find a way to treat multiple sclerosis

and more »

View full post on asthma – Google News

Mice at risk of asthma, allergies can fight off skin cancer – Washington University in St. Louis News


Washington University in St. Louis News

Mice at risk of asthma, allergies can fight off skin cancer
Washington University in St. Louis News
A molecule involved in asthma and allergies now has been shown to make mice resistant to skin cancer, according to scientists at Washington University School of Medicine in St. Louis. The molecule, called TSLP (thymic stromal lymphopoietin), is

and more »

View full post on asthma – Google News

Proteome changes in auricular lymph nodes and serum after dermal sensitization to toluene diisocyanate in mice.

Proteome changes in auricular lymph nodes and serum after dermal sensitization to toluene diisocyanate in mice.

Proteomics. 2012 Oct 4;

Authors: Haenen S, Clynen E, De Vooght V, Schoofs L, Nemery B, Hoet PH, Vanoirbeek JA

Abstract
Some reactive chemicals, such as diisocyanates, are capable of initiating an allergic response, which can lead to occupational asthma after a latency period. Clinical symptoms such as cough, wheezing and dyspnea occur only late, making it difficult to intervene at an early stage. So far, most studies using proteomics in lung research have focused on comparisons of healthy vs. diseased subjects. Here, using two-dimensional difference gel electrophoresis (2D-DIGE), we explored proteome changes in the local draining lymph nodes and serum of mice dermally sensitized once or twice with TDI before asthma is induced. In the lymph nodes, we found 38 and 58 differentially expressed proteins after one and two treatments, respectively, between toluene diisocyanate-treated and vehicle-treated mice. In serum, 7 and 16 differentially expressed proteins were detected after one and two treatments, respectively. We identified 80-85% of the differentially expressed proteins by mass spectrometry. Among them, lymphocyte specific protein-1, coronin 1a and hemopexin were verified by Western blotting or ELISA in an independent group of mice. This study revealed alterations in the proteomes early during sensitization in a mouse model before the onset of chemical-induced asthma. If validated in humans, these changes could lead to earlier diagnosis of TDI-exposed workers.

PMID: 23038679 [PubMed – as supplied by publisher]

View full post on pubmed: asthma

Chlamydia muridarum Lung Infection in Infants Alters Hematopoietic Cells to Promote Allergic Airway Disease in Mice.

Related Articles

Chlamydia muridarum Lung Infection in Infants Alters Hematopoietic Cells to Promote Allergic Airway Disease in Mice.

PLoS One. 2012;7(8):e42588

Authors: Starkey MR, Kim RY, Beckett EL, Schilter HC, Shim D, Essilfie AT, Nguyen DH, Beagley KW, Mattes J, Mackay CR, Horvat JC, Hansbro PM

Abstract
BACKGROUND: Viral and bacterial respiratory tract infections in early-life are linked to the development of allergic airway inflammation and asthma. However, the mechanisms involved are not well understood. We have previously shown that neonatal and infant, but not adult, chlamydial lung infections in mice permanently alter inflammatory phenotype and physiology to increase the severity of allergic airway disease by increasing lung interleukin (IL)-13 expression, mucus hyper-secretion and airway hyper-responsiveness. This occurred through different mechanisms with infection at different ages. Neonatal infection suppressed inflammatory responses but enhanced systemic dendritic cell:T-cell IL-13 release and induced permanent alterations in lung structure (i.e., increased the size of alveoli). Infant infection enhanced inflammatory responses but had no effect on lung structure. Here we investigated the role of hematopoietic cells in these processes using bone marrow chimera studies.
METHODOLOGY/PRINCIPAL FINDINGS: Neonatal (<24-hours-old), infant (3-weeks-old) and adult (6-weeks-old) mice were infected with C. muridarum. Nine weeks after infection bone marrow was collected and transferred into recipient age-matched irradiated naïve mice. Allergic airway disease was induced (8 weeks after adoptive transfer) by sensitization and challenge with ovalbumin. Reconstitution of irradiated naïve mice with bone marrow from mice infected as neonates resulted in the suppression of the hallmark features of allergic airway disease including mucus hyper-secretion and airway hyper-responsiveness, which was associated with decreased IL-13 levels in the lung. In stark contrast, reconstitution with bone marrow from mice infected as infants increased the severity of allergic airway disease by increasing T helper type-2 cell cytokine release (IL-5 and IL-13), mucus hyper-secretion, airway hyper-responsiveness and IL-13 levels in the lung. Reconstitution with bone marrow from infected adult mice had no effects.
CONCLUSIONS: These results suggest that an infant chlamydial lung infection results in long lasting alterations in hematopoietic cells that increases the severity of allergic airway disease in later-life.

PMID: 22870337 [PubMed – in process]

View full post on pubmed: asthma

Potential Cause of Asthma-Like Symptoms Spotted in Mice – BusinessWeek

Potential Cause of Asthma-Like Symptoms Spotted in Mice
BusinessWeek
29 (HealthDay News) — A possible genetic basis for severe asthma has been identified by researchers, and although the findings are based on a study in mice
Protein linked to severe asthmaThe Press Association
Study Points to Key Genetic Driver of Severe Allergic AsthmaPR Newswire (press release)

all 21 news articles »

View full post on asthma – Google News

Potential Cause of Asthma-Like Symptoms Spotted in Mice – U.S. News & World Report

Potential Cause of Asthma-Like Symptoms Spotted in Mice
U.S. News & World Report
29 (HealthDay News) — A possible genetic basis for severe asthma has been identified by researchers, and although the findings are based on a study in mice
Protein linked to severe asthmaThe Press Association
Study Points to Key Genetic Driver of Severe Allergic AsthmaPR Newswire (press release)

all 16 news articles »

View full post on asthma – Google News